Ad Scientiam Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ad Scientiam's estimated annual revenue is currently $9.1M per year.(i)
  • Ad Scientiam's estimated revenue per employee is $130,500

Employee Data

  • Ad Scientiam has 70 Employees.(i)
  • Ad Scientiam grew their employee count by 6% last year.

Ad Scientiam's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Product OwnerReveal Email/Phone
3
Co-founder - UX DesignerReveal Email/Phone
4
Chief Data OfficerReveal Email/Phone
5
Head Clinical ResearchReveal Email/Phone
6
Head ProductReveal Email/Phone
7
Head PlatformReveal Email/Phone
8
Head Software EngineeringReveal Email/Phone
9
Head Medical AffairsReveal Email/Phone
10
Head legal - Data Protection OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$114.2M6233%N/AN/A
#2
$4.9M38-5%N/AN/A
#3
$60M35916%$102MN/A
#4
$8.1M6235%N/AN/A
#5
$6.8M49-2%N/AN/A
#6
$5.2M42-2%N/AN/A
#7
$24.6M1619%N/AN/A
#8
$12.5M8613%N/AN/A
#9
$2.9M29-29%N/AN/A
#10
$12.5M841%N/AN/A
Add Company

What Is Ad Scientiam?

REAL-WORLD MOBILE SOLUTIONS TO MONITOR CHRONIC DISEASES The challenge: Insufficient information to understand chronic diseases and provide care (retrospective, limited, biased). Our Answer: Tailored monitoring and assessment solutions, developed with Healthcare Professionals (HCP) -Self-assessment by patients of their disease and its progression, at home -Real-life and continuous monitoring by HCPs Scientifically-validated tests leveraging smartphone capabilities (cognition, dexterity, vision…) and custom digital services (exercises, adherence advice…) Benefits For our final users: • Patients: empowerment, more precise monitoring, more personalized care • Physicians: better-informed decision taking, reinforced link with patients For our partners: • Researchers and Pharma: real-world data to assess economic value of indications and feed future R&D • Payers and providers: reduction of avoidable in-patient time, anticipation of complications, differentiating service to client base Who we are • Digital Health startup, created in 2013 and incubated in a leading Research Hospital in France • Multidisciplinary team (Medical, Clinical, Stats, UX, Business…) with strong experience in healthcare and pharma • Numerous research and technical partnerships • Award winning IT platform Achievements and ongoing projects • 15+ clinical studies conducted with leading research teams in Europe and in the US • Solutions developed in Multiple Sclerosis and Occupational burnout • Ambitious pipeline (rheumatoid arthritis, resistant depression, insomnia, Parkinson's, Alzheimer's…)

keywords:N/A

N/A

Total Funding

70

Number of Employees

$9.1M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ad Scientiam News

2022-04-17 - Quand les scientifiques étudient le paranormal

1- Camille Flammarion, l'astronome qui étudie le spiritisme. Ad veritatem per scientiam, "La vérité par la science" : cette devise est gravée...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M7011%N/A
#2
$7.9M7019%N/A
#3
$13.2M70-12%N/A
#4
$9.3M703%N/A
#5
$11.2M70-5%N/A